1. 1659. Pharmacokinetics/pharmacodynamics of the Novel Gyrase Inhibitor SPR719/SPR720 and Clinical Dose Selection to Treat Pulmonary Mycobacterium avium-complex Disease. (31st December 2020) Authors: Deshpande, Devyani; Kuret, Daniel; Cirrincione, Kayle; Cotroneo, Nicole; Melnick, David; Lister, Troy; Stokes, Suzanne; Gumbo, Tawanda Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1695. Combination Therapy for the Investigational Polymyxin SPR206 and Meropenem (MEM) Increases the Rapidity and Extent of Killing of Pseudomonas aeruginosa (PA) and Prevents the Bacterium from Emerging Resistant to Both Antibiotics. (15th December 2022) Authors: Louie, Arnold; Bader, Justin; Cotroneo, Nicole; Lister, Troy; Liu, Weiguo; Brown, David; Myrick, Jenny; Drusano, George Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 625. SPR206 Pharmacokinetics (PK) in Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) in Healthy Adult Subjects. (15th December 2022) Authors: Rodvold, Keith A; Bader, Justin; Gupta, Vipul K; Lister, Troy; Srivastava, Praveen; Bruss, Jon Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antibiotic drug discovery : new targets and molecular entities /: new targets and molecular entities. (2017) Editors: Firestine, Steven M; Lister, Troy Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antibiotic drug discovery. (2017) Editors: Firestine, Steven M; Lister, Troy; Thurston, David E Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ChemInform Abstract: New Natural Products as New Leads for Antibacterial Drug Discovery. Issue 11 (18th March 2014) Authors: Brown, Dean G.; Lister, Troy; May‐Dracka, Tricia L. Journal: ChemInform Issue: Volume 45:Issue 11(2014) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. New antibacterial agents: patent applications published in 2011. (January 2014) Authors: Keating, Thomas A; Lister, Troy; Verheijen, Jeroen C Journal: Pharmaceutical patent analyst Issue: Volume 3:Number 1(2014) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New antibacterial agents: patent applications published in 2011. (January 2014) Authors: Keating, Thomas A; Lister, Troy; Verheijen, Jeroen C Journal: Pharmaceutical patent analyst Issue: Volume 3:Number 1(2014) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Potential strategies for increasing drug-discovery productivity. (April 2014) Authors: Cumming, John G; Finlay, M Raymond V; Giordanetto, Fabrizio; Hemmerling, Martin; Lister, Troy; Sanganee, Hitesh; Waring, Michael J Journal: Future medicinal chemistry Issue: Volume 6:Number 5(2014) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment of Gram-negative bacterial infections by potentiation of antibiotics. (October 2016) Authors: Zabawa, Thomas P; Pucci, Michael J; Parr, Thomas R; Lister, Troy Journal: Current opinion in microbiology Issue: Volume 33(2016) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗